Toward operative in vivo fluorescence imaging of the c‐Met proto‐oncogene for personalization of therapy in ovarian cancer
<p style="text-align:justify;"> <b>BACKGROUND:</b> Standard biomarker testing of a single macroscopic disease site is unlikely to be sufficient because of tumor heterogeneity. A focus on examining global biomarker expression or activity, particularly in microscopic resid...
Main Authors: | Liu, S, Zheng, Y, Volpi, D, El-Kasti, M, Klotz, D, Tullis, I, Henricks, A, Campo, L, Myers, K, Laios, A, Thomas, P, Ng, T, Dhar, S, Becker, C, Vojnovic, B, Ahmed, A |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Wiley
2014
|
Similar Items
-
Toward operative in vivo fluorescence imaging of the c-Met proto-oncogene for personalization of therapy in ovarian cancer.
by: Liu, S, et al.
Published: (2015) -
A prospective pilot study of detection of sentinel lymph nodes in gynaecological cancers using a novel near infrared fluorescence imaging system
by: Laios, A, et al.
Published: (2015) -
Leukocyte cell-derived chemotaxin 2 is an antiviral regulator acting through the proto-oncogene MET
by: Takayoshi Shirasaki, et al.
Published: (2022-06-01) -
Activation of proto-oncogenes by disruption of chromosome neighborhoods
by: Hnisz, D., et al.
Published: (2017) -
A prospective pilot study of detection of sentinel lymph nodes in gynaecological cancers using a novel near infrared fluorescence imaging system
by: Laios, A, et al.
Published: (2015)